← Leaderboards
Robert Ernst
University Of Maryland Baltimore
$5,929,828
Attributed
$5,929,828
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2019–22$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$5,929,828 · 1
By mechanism
N01$5,929,828 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Marcelo B. Sztein$36,733,861
- James B Kaper$25,841,976
- Myron Max Levine$22,681,817
- Karen L. Kotloff$76,457,208
- Marcela F Pasetti$26,884,335
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantEngineeringHuman DiseaseImmunologicsInvestigationLicensureLigandsPathogenProgram DevelopmentShigellaSupport ContractsVaccinesYersinia Pestis
Grant awards (3)
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.$1,388,963
N01 · FY2022 · AI · contact PI
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.$2,143,971
N01 · FY2021 · AI · contact PI
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.$2,396,894
N01 · FY2019 · AI · contact PI